Literature DB >> 10051548

Phenylketonuria: old disease, new approach to treatment.

H L Levy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10051548      PMCID： PMC33523          DOI： 10.1073/pnas.96.5.1811

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  38 in total

1.  Influence of phenylalanine intake on phenylketonuria.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Lancet       Date:  1953-10-17       Impact factor: 79.321

2.  Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials.

Authors:  A P Prince; M P McMurray; N R Buist
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

3.  Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase.

Authors:  S C Kwok; F D Ledley; A G DiLella; K J Robson; S L Woo
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

4.  Correction of phenylketonuria after liver transplantation in a child with cirrhosis.

Authors:  P Vajro; P Striscìuglio; D Houssin; G Huault; J Laurent; F Alvarez; O Bernard
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

5.  Prenatal diagnosis and carrier detection of classic phenylketonuria by gene analysis.

Authors:  S L Woo
Journal:  Pediatrics       Date:  1984-09       Impact factor: 7.124

Review 6.  Maternal phenylketonuria: a metabolic teratogen.

Authors:  H L Levy; M Ghavami
Journal:  Teratology       Date:  1996-03

7.  A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase.

Authors:  C N Sarkissian; Z Shao; F Blain; R Peevers; H Su; R Heft; T M Chang; C R Scriver
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.

Authors:  J Weglage; K Ullrich; M Pietsch; B Fünders; F Güttler; E Harms
Journal:  Pediatr Res       Date:  1997-09       Impact factor: 3.756

9.  The North American Collaborative Study of Maternal Phenylketonuria. Status report 1993.

Authors:  R Koch; H L Levy; R Matalon; B Rouse; W Hanley; C Azen
Journal:  Am J Dis Child       Date:  1993-11

10.  Mouse models of human phenylketonuria.

Authors:  A Shedlovsky; J D McDonald; D Symula; W F Dove
Journal:  Genetics       Date:  1993-08       Impact factor: 4.562
View more
  11 in total

1.  PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice.

Authors:  Jennifer E Embury; Catherine E Charron; Anatoly Martynyuk; Andreas G Zori; Bin Liu; Syed F Ali; Neil E Rowland; Philip J Laipis
Journal:  Brain Res       Date:  2006-11-15       Impact factor: 3.252

2.  Ethical issues raised by personalized nutrition based on genetic information.

Authors:  Ulf Görman
Journal:  Genes Nutr       Date:  2006-03       Impact factor: 5.523

Review 3.  What we know that could influence future treatment of phenylketonuria.

Authors:  C N Sarkissian; A Gámez; C R Scriver
Journal:  J Inherit Metab Dis       Date:  2008-08-03       Impact factor: 4.982

Review 4.  State-of-the-art 2003 on PKU gene therapy.

Authors:  Zhaobing Ding; Cary O Harding; Beat Thöny
Journal:  Mol Genet Metab       Date:  2004-01       Impact factor: 4.797

5.  Biochemical characterization of mutant phenylalanine hydroxylase enzymes and correlation with clinical presentation in hyperphenylalaninaemic patients.

Authors:  S F Dobrowolski; A L Pey; R Koch; H Levy; C C Ellingson; E W Naylor; A Martinez
Journal:  J Inherit Metab Dis       Date:  2008-10-21       Impact factor: 4.982

6.  Structural basis for the entrance into the phenylpropanoid metabolism catalyzed by phenylalanine ammonia-lyase.

Authors:  Holger Ritter; Georg E Schulz
Journal:  Plant Cell       Date:  2004-11-17       Impact factor: 11.277

7.  Interactive effects of neonatal exposure to monosodium glutamate and aspartame on glucose homeostasis.

Authors:  Kate S Collison; Nadine J Makhoul; Marya Z Zaidi; Rana Al-Rabiah; Angela Inglis; Bernard L Andres; Rosario Ubungen; Mohammed Shoukri; Futwan A Al-Mohanna
Journal:  Nutr Metab (Lond)       Date:  2012-06-14       Impact factor: 4.169

8.  Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity.

Authors:  Kate S Collison; Nadine J Makhoul; Marya Z Zaidi; Soad M Saleh; Bernard Andres; Angela Inglis; Rana Al-Rabiah; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

9.  Situating Nutri-Ethics at the Junction of Nutrigenomics and Nutriproteomics in Postgenomics Medicine.

Authors:  Nicola Luigi Bragazzi
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-06

10.  A field-grown transgenic tomato line expressing higher levels of polyamines reveals legume cover crop mulch-specific perturbations in fruit phenotype at the levels of metabolite profiles, gene expression, and agronomic characteristics.

Authors:  Anil Neelam; Tatiana Cassol; Roshni A Mehta; Aref A Abdul-Baki; Anatoli P Sobolev; Ravinder K Goyal; Judith Abbott; Anna L Segre; Avtar K Handa; Autar K Mattoo
Journal:  J Exp Bot       Date:  2008-05-09       Impact factor: 6.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.